Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve ,inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st Extraordinary General Meeting and/or issue the corrigendum pertains to that item or matters related thereto.